Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. There pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response
Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. There pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response
Top 10 Most Recent Blog Posts
Assessing Risk Tolerance: A Guide for Smart Investors
Category: Investing Total Views: 128By : Editor Updated: 05-16-2024
Finding Undervalued Penny Stocks: Strategies for Success
Category: Stocks Total Views: 145By : Editor Updated: 05-16-2024
Stock Market Recap: Winners and Inflation - May 15, 2024
Category: Stocks Total Views: 93By : Editor Updated: 05-15-2024
Are Meme Stocks Simply Modern Pump and Dumps?
Category: Stocks Total Views: 180By : Editor Updated: 05-15-2024
Stock Market Midday Update - May 15, 2024
Category: Markets Total Views: 158By : Editor Updated: 05-15-2024
Stock Market Morning Session: Meme Mania - May 15, 2024
Category: Markets Total Views: 187By : Editor Updated: 05-15-2024
The Rapidly Changing Real Estate Sector - May 14, 2024
Category: Real Estate Total Views: 197By : Editor Updated: 05-14-2024
Today's Stock Market Performance and Overview - May 14, 2024
Category: Stocks Total Views: 202By : Editor Updated: 05-14-2024
Unraveling Mortgage Rates: Insider Views and Housing Challenges
Category: Real Estate Total Views: 249By : Editor Updated: 05-14-2024
Uncovering Buffett's Moves & AI Trends: A Q1 Investing Deep Dive
Category: Investing Total Views: 251By : Editor Updated: 05-14-2024